Lassman Law+Policy was recognized by U.S. News & World Report as one of the Best Law Firms in Washington, D.C. in the areas of FDA Law and Administrative/Regulatory Law for 2020. This is the first time the firm has been recognized on this prestigious list.

Scott M. Lassman recently was recognized by LMG Life Sciences as a Regulatory Law Star in the areas of pharmaceutical and medical device regulatory law for 2020.

LMG Life Sciences evaluates attorneys on the basis of case evidence, peer feedback and client feedback.

Scott M. Lassman recently was recognized by The Best Lawyers in America as one of the leading lawyers in America in the categories of FDA Law and Administrative/Regulatory Law.

Best Lawyers' recognitions are based purely on the feedback received from lawyers already highlighted in the publication.

Chambers USA recently recognized Scott M. Lassman as a leading attorney (Band 2) in the category of Healthcare: Pharmaceutical/Medical Products Regulatory. Chambers USA specifically highlighted his ability to provide practical solutions to complex regulatory issues, his efficiency, and his "deep knowledge of Hatch-Waxman."

Scott M. Lassman was recently recognized by Who's Who Legal as a recommended regulatory attorney in its Life Sciences 2020 guide.

The Who's Who Legal research process is based on recommendations and feedback from eminent private practitioners in the sector as well as from corporate counsel.

Scott M. Lassman recently was recognized by LMG Life Sciences as a Regulatory Law Star in the areas of pharmaceutical and medical device regulatory law for 2019.

LMG Life Sciences evaluates attorneys on the basis of case evidence, peer feedback and client feedback.

Scott M. Lassman recently was recognized by The Best Lawyers in America as one of the leading lawyers in America in the categories of FDA Law and Administrative/Regulatory Law.

Best Lawyers' recognitions are based purely on the feedback received from lawyers already highlighted in the publication.

Lassman Law+Policy recently was honored by LMG Life Sciences by being placed on its "Shortlist" of Regulatory Firms to Watch in 2019. Lassman Law+Policy is the only boutique firm specializing in FDA regulatory law to be recognized in that category. Congratulations to the other nominees: Akin Gump, Debevoise & Plimpton, and Mayer Brown!

LMG Life Sciences evaluates attorneys on the basis of case evidence, peer feedback and client feedback.